A Conversation with Troy Groetken and Outsourced Pharma about “What Happens When IP is Redistributed? CDMOs Without Borders”


In a follow-up article with Outsourced Pharma about the IP waiver, Troy Groetken showcases his support for current manufacturers, their chosen trusted suppliers, and the ability to add scalability and capacity without sacrificing quality.

Read the full article here.